Clinical Trial

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2025-03-07; most recent amendment 2025-12-03.
Status change: Recruiting → Active, Not Recruiting 2025-12-03
Status change: Not Yet Recruiting → Recruiting 2025-03-26
Trial Details
NCT Number NCT06868264
Lead Sponsor Atea Pharmaceuticals, Inc.
Conditions HEPATITIS C VIRUS CHRONIC INFECTION
Enrollment 880 participants
Start Date 2025-04-07
Primary Completion 2026-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-05